Open Data

Paris, 26 janvier 2015 La ministre de la Santé Marisol Touraine a réaffiché son ambition de faciliter l’accès aux données de santé, qualifiant leur ouverture de “mouvement incontournable”, lundi en marge de la présentation de projets exploitant les informations de l’Assurance maladie, à Paris. Pour lire l’article de l’Express

2013 fut marqué par la bataille des industriels de santé pour l’ouverture des données de santé. 2014 s’est achevé sur le combat des professionnels de santé pour une ouverture respectueuse du secret médical. 2015 pourrait rester dans les annales comme l’année du hold-up sur les données de santé ! Pour lire l’article de Pierre Desmarais

The health care giant Johnson & Johnson has agreed to make detailed clinical trial data on its medical devices and diagnostic tests available to outside researchers through a collaboration with Yale University, making it the first large device manufacturer to systematically make such data public. The announcement came on the same day that the Institute of Medicine, of the National Academy of Sciences, called on all sponsors of clinical trials to share detailed study data with outside researchers and recommended that such data be made available within 30 days of a product’s approval. The dual developments are part of a …

The European Medicines Agency (EMA) has now adopted its policy about access to clinical trial data,1 more than a year after the release of the first draft for public consultation. Although intended to boost accountability and trust in medical research, the policy does not seem to meet such expectations. The main concern is with respect to which data and documents can be accessed. The policy applies only to dossiers submitted through the centralised procedures from 2015. Pharmacovigilance data are not deemed in the policy. Before publication, the holder of marketing authorisation could edit clinical overviews, study summaries, and reports to …

Cliquez sur l’image pour accéder à cet Webzine du CNOM 🙂